Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US8084461B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2005 |
| Grant date | Dec 27, 2011 |
| Priority date | — |
| Expiry date | Jun 10, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4745
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide in a 0.5 ml volume.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.